EQUITY-METHOD INVESTMENTS (Tables)

3 Months Ended

Mar. 31, 2020

Equity Method Investments and Joint Ventures [Abstract]

Schedule of Condensed Financial Information of Equity Method Investments

The following presents condensed financial information as of March 31, 2020 and December 31, 2019 and for the three months ended March 31, 2020 and 2019 (in thousands).

Consolidated statements of comprehensive income (loss) data:
	Three Months Ended March 31,
	2020		2019
Net revenue	$	10,508	$	9,238
Cost of revenue	8,640		7,049
Gross profit	1,868		2,189
Net income	608		847
Equity in net income	304		424
Consolidated balance sheet data:
	As of
	March 31, 2020		December 31, 2019
Current assets	12,086		11,111
Noncurrent assets	1,862		2,033
Current liabilities	1,528		1,228
Noncurrent liabilities	852		956

The following presents condensed financial information as of March 31, 2020 and December 31, 2019 and for the three months ended March 31, 2020 and 2019 (in thousands).

Consolidated statements of comprehensive income (loss) data:
	Three Months Ended March 31,
	2020		2019
Net revenue	$	5,491	$	4,775
Cost of revenue	3,940		3,367
Gross profit	1,551		1,408
Net income	517		250
Equity in net income	258		125
Consolidated balance sheet data:
	As of
	March 31, 2020		December 31, 2019
Current assets	$	7,482	$	7,643
Noncurrent assets	3,615		3,846
Current liabilities	1,074		903
Noncurrent liabilities	579		659